Search

everythinglearnresearchcommunity

for

Search:↓

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

The new system greatly improves carvedilol's solubility and effectiveness.

Niosomes and ethosomes can effectively carry the drug spironolactone, potentially improving treatment for hair loss and reducing side effects.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Taking the same medication under different brand names caused harmful side effects.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

SEREVELLE safely and effectively promotes hair growth in adults with thinning hair.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

A new accurate and reliable method was developed to measure Spironolactone and Hydrochlorothiazide together in medicines.

SesZen-Bio™ improves hair density, thickness, and overall hair health.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Nanosuspension increased finasteride's water solubility by over 2.5 times.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

High doses of some selenium supplements caused liver and reproductive harm in rats.

A 6-year-old girl had a rare allergic reaction to a hair regrowth treatment.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Promising cancer treatments were found, but the manufacturer closed.

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.